openPR Logo
Press release

Carbamazepine Market: Industry Survey and Outlook 2025

05-31-2017 12:52 PM CET | Health & Medicine

Press release from: TMR Research

Global Carbamazepine Market: Overview

Carbamazepine sold under the brand names of Carbatrol, Epitol, Tegretol, Equetro, and TEGretol-XR., is a drug used primarily for the treatment of epilepsy and neuropathic pain. It is also used for schizophrenia as an alternate line of treatment as well as for bipolar disorder. The increasing demand for carbamazepine for the treatment of various types of seizures and bipolar disorders is expected to drive the global carbamazepine market in the next few years.

Carbamazepine is a white or yellowish-white crystalline powder, which is almost odorless. Carbamazepine is tasteless or has a slightly bitter taste. Carbamazepine are available as chewable tablet, suspension, tablet, extended release tablet, and extended release capsule.

Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=446

Carbamazepine is suitable for the treatment of status epilepticus. Moreover, carbamazepine is utilized in the treatment of trigeminal neuralgia. Carbamazepine is utilized for the pain relief of idiopathic trigeminal and trigeminal neuralgia due to multiple sclerosis and also for the pain relief of idiopathic glossopharyngeal neuralgia. However, carbamazepine is not a simple analgesic and is not suitable to be used for trivial facial pain or headache. Moreover, carbamazepine is used for the treatment of mania and for maintaining the treatment of bipolar affective disorders or to prevent recurrence. However, carbamazepine is not effective in treating absence seizures, myoclonic seizures, and atonic seizures. Also, carbamazepine is not suitable for treating status epilepticus.

The report presents a detailed assessment of the market dynamics, growth trends, and opportunities that will impact the progression of the global carbamazepine market between 2017 and 2025. The report has been collated using primary and secondary research methodologies to present an exact case of this market. The report is focused on presenting a granular view of the various market segments along with the factors influencing them.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=446

The report discuss the vendor landscape of the global carbamazepine market at length. This includes a competitive profile of the key vendors pertaining to their attributes of product specification and portfolio, financial standing, and recent developments. It also includes an analysis of the indices of strengths, weakness, opportunities, and threats of these vendors during the forecast period. Finally, the report includes comments and recommendations from industry experts for new and existing players.

Global Carbamazepine Market: Trends and Opportunities

The FDA has approved the medical use of carbamazepine for epilepsy, manic episodes of bipolar disorders, and trigeminal neuralgia. A controlled release formulation about carbamazepine was available by the FDA as of 2014, which provides tentative evidence regarding fewer side effects of the drug.

Read Comprehensive Overview of Report@ https://www.tmrresearch.com/carbamazepine-market

The dynamic growth of the epilepsy market with the increasing number of cases in the mid-teen age group is presenting lucrative growth opportunities to the carbamazepine market. For instance, in the U.S., the use of newer therapies for epilepsy and bipolar depression has witnessed a fourfold increase. The increasing number of individuals suffering from alcohol withdrawal disorders, central partial diabetes insipidus or water diabetes, and psychotic disorders is also driving the carbamazepine market.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth researh of the market, we try to bring about game-changing success for our clients.

Contact :

Rohit Bhisey
Head - Internet Marketing
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carbamazepine Market: Industry Survey and Outlook 2025 here

News-ID: 557843 • Views:

More Releases from TMR Research

Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - 2031
Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - …
Automotive Vision System Market: Introduction A system that increases the vehicle driver's perception during night or bad weather conditions is termed as Automotive night vision system (ANVS). The system is otherwise beyond the reach of the vehicle's headlights, thereby prevents accidents at night. It can also be defined as a system which assists the driver by increasing visibility during bad whether while providing safety. Vehicle which have automotive vision system integrated are
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market: Snapshot The waste heat recovery market has been expected to reach a valuation of US$ 65.87 Bn and expand at a CAGR of 6.90% in the foreseeable years from 2020 to 2030. The growth opportunities in the waste heat recovery market are attributed to the increasing prices of electricity and energy in the emerging economies. In addition to this, government regulations and incentives are also estimated to contribute
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2021 to 2031.
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Ma …
Global Physical Fitness Equipment Market: Snapshot The physical fitness equipment market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2020 to 2030. The revenue generation opportunities in the physical fitness equipment market are attributed to the increasing enthusiasm among people toward fitness. In recent years, the fitness industry has been growing at a noticeable speed owing to
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Growing Regions like North America, Europe and Asia Pacific.
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Grow …
Global Molecular Spectrometry Market: Snapshot  Molecular spectrometry examines and quantifies the response of molecules on interaction with known amounts of energy. Molecules have some energy levels that can be studied by determining the molecule's energy exchange through emission or absorbance. Molecular spectrometry involves studying emission, absorption, or scattering of electromagnetic waves by atoms or molecules to quantitatively and qualitatively study atoms, molecules or physical processes. The interaction of matter with radiation

All 5 Releases


More Releases for Carbamazepine

Carbamazepine Market detailed assessment of dynamic growth 2025
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the
Carbamazepine Market Bestowing Current Demand till 2025
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the
Carbamazepine Market Dynamic Growth Rate by 2025
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the
Carbamazepine Market - Advancements,Innovations Of Industry & Forecast 2017 - 20 …
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the
Carbamazepine Market : Industry Analysis,Trends and Forecast 2017 - 2025
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the
Carbamazepine Market – Companies, applications, products and more 2025
Global Carbamazepine Market: Snapshot Under various brand names such as Epitol, Carbatrol, Tegretol, and Tegretol XR, carbamazepine drugs are used for the treatment of a number of diseases such as borderline personality disorder, bipolar disorder, cyclothymic disorder, occipital neuralgia, peripheral neuropathy, cluster-tic syndrome, dystonia, epilepsy, diabetic peripheral neuropathy, reflex sympathetic dystrophy syndrome, vulvodynia, schizoaffective disorder, and trigeminal neuralgia. In October 2016, the Food and Drug Administration (FDA) approved carnexiv for the